A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

NHS England appeals for 1.3 million eligible people to come forward for a new jab against respiratory syncytial virus (RSV) ...

It appears RSV and COVID have peaked, but the flu is still rising. The number and rate of positive cases of COVID is notably ...

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

“Areas with lower vaccination rates, colder weather and higher population density are seeing higher infection rates,” said Dr ...

Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

Right now, local hospitals are seeing more kids come in with bronchiolitis. The cases are mostly from RSV, which impacts the small airways in the lungs.

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

The CDC recommends everyone 6 months and older get the 2024-2025 COVID and flu vaccines. Trump says he paused US tariffs on ...